DNLI Stock: Price, Earnings History and SEC Filings
Denali Therapeutics Inc. (DNLI) last traded at $18.94, down 1.97% on the latest session and down 8.4% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.68 against an analyst estimate of $-0.72, a beat of 5.6%.
$18.94 -1.97%
1 month-8.37%
52-week high$27.30
52-week low$13.75
Volume1.31M
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
DNLI earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $-0.68 | $-0.72 | +5.56% |
| Mar 2026 | May 7, 2026 | $-0.69 | $-0.73 | +5.48% |
| Dec 2025 | Feb 26, 2026 | $-0.73 | $-0.75 | +2.67% |
| Sep 2025 | Nov 6, 2025 | $-0.74 | $-0.76 | +2.63% |
DNLI beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
DNLI financial history
Revenue
Net income
Free cash flow
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $0 | -$513M | -$422M | – | $-2.97 |
| 2024 | $0 | -$423M | -$364M | – | $-2.57 |
| 2023 | $331M | -$145M | -$371M | -43.9% | $-1.06 |
| 2022 | $105M | -$326M | -$263M | -310.3% | $-2.60 |
| 2021 | $49M | -$291M | -$220M | -597.2% | $-2.39 |
| 2020 | $336M | $71M | $413M | 21.2% | $0.63 |
| 2019 | $26M | -$198M | -$169M | -750.8% | $-2.07 |
| 2018 | $129M | -$36M | $47M | -28.1% | $-0.39 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for DNLI
SEC filing data is not available right now. You can search for DNLI on SEC EDGAR.
DNLI news
- Denali Therapeutics Receives 2026 Prix Galien USA Award for AVLAYAH® (tividenofusp alfa-eknm) as Best Biotechnology ProductOct 30, 2026 · finance.yahoo.com
- Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026Oct 22, 2026 · finance.yahoo.com
- DNLI stock: November 5 results date guides Denali Therapeutics stockOct 22, 2026 · ad-hoc-news.de
About Denali Therapeutics Inc.
Denali Therapeutics Inc. (DNLI) is a US-listed public company on Nasdaq.